NFSG
TBPH icon

Newbridge Financial Services Group’s Theravance Biopharma TBPH Stock Holding History

Newbridge Financial Services Group’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,000
Closed -$8.97K – 1224
2024
Q1 		$8.97K Hold
1,000
– – ﹤0.01% 796
2023
Q4 		$11.2K Hold
1,000
– – 0.01% 710
2023
Q3 		$8.63K Hold
1,000
– – ﹤0.01% 853
2023
Q2 		$10.3K Sell
1,000
-1,000
-50% -$11K 0.01% 882
2023
Q1 		$21.7K Hold
2,000
– – 0.01% 683
2022
Q4 		$22.4K Hold
2,000
– – 0.01% 683
2022
Q3 		$20K Hold
2,000
– – 0.01% 699
2022
Q2 		$18K Hold
2,000
– – 0.01% 693
2022
Q1 		$19K Hold
2,000
– – 0.01% 750
2021
Q4 		$22K Hold
2,000
– – 0.01% 702
2021
Q3 		$15K Hold
2,000
– – 0.01% 755
2021
Q2 		$29K Buy
+2,000
New +$37.6K 0.02% 658

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Newbridge Financial Services Group's TBPH Position: Q2 2024 in Review

Newbridge Financial Services Group sold out of Theravance Biopharma (TBPH) in Q2 2024, closing a stake of 1,000 shares — an estimated $8.97K sold.

Newbridge Financial Services Group first reported a position in TBPH in Q2 2021 and held it in 12 quarters. The position peaked at $29K in Q2 2021. 132 funds tracked by Wall St. Rank hold TBPH as of Q2 2024.

  • Newbridge Financial Services Group reported no remaining Theravance Biopharma position as of Q2 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 1,000 Theravance Biopharma shares in Q2 2024, an estimated $8.97K.
  • Newbridge Financial Services Group first reported a position in Theravance Biopharma in Q2 2021 and held it in 12 quarters.
  • Newbridge Financial Services Group's Theravance Biopharma position peaked at $29K in Q2 2021.
  • 132 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2024.

Based on Newbridge Financial Services Group's 13F filing for Q2 2024, filed 11 Sep 2024.